Combinatorial assessment of ctDNA release and mutational burden predicts anti-PD(L)1 therapy outcome in nonsmall-cell lung cancer

Lung Cancer
08/06/2020

Fang W, et al. Clin Transl Med 2020.

NO ABSTRACT